Related Experiment Videos

Leukocyte count and risk of major coronary heart disease events

A N Phillips1, J D Neaton, D G Cook

  • 1Department of Public Health and Primary Care, Royal Free Hospital School of Medicine, London, England.

Insights

Higher leukocyte counts in middle-aged men are linked to an increased risk of major coronary heart disease events. This finding suggests leukocyte count may serve as a valuable indicator for future cardiovascular risk assessment.

Area of Science:

  • Cardiology
  • Hematology
  • Epidemiology

Background:

  • Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
  • Identifying reliable biomarkers for predicting CHD risk is crucial for preventive strategies.
  • Previous research has suggested potential links between inflammation markers and cardiovascular events.

Purpose of the Study:

  • To investigate the association between baseline leukocyte count and the risk of major coronary heart disease events.
  • To determine if leukocyte count is an independent predictor of future cardiovascular events.
  • To assess this association across different cohorts and smoking statuses.

Main Methods:

  • Utilized data from three large prospective cohort studies (US and UK).
  • Included 28,181 middle-aged men followed for 6-12 years.
  • Analyzed the relationship between baseline leukocyte count and major CHD events (nonfatal myocardial infarction or CHD death), adjusting for key risk factors.

Main Results:

  • A positive and statistically significant association was observed between higher leukocyte counts and increased risk of major CHD events across all cohorts.
  • Relative odds for a 2,000/mm3 difference in leukocyte count ranged from 1.14 to 1.32 (p < 0.003).
  • The association remained significant after excluding smokers and individuals with pre-existing CHD.

Conclusions:

  • Elevated leukocyte count is a significant predictor of future major coronary heart disease events.
  • Leukocyte count may serve as a valuable, independent biomarker for assessing cardiovascular risk.
  • These findings support the role of inflammation in the pathogenesis of coronary heart disease.

Related Concept Videos